BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vere G, Alam MR, Farrar S, Kealy R, Kessler BM, O’brien DP, Pinto-fernández A. Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19. Biomolecules 2022;12:300. [DOI: 10.3390/biom12020300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Perdalkar S, Basthi Mohan P, Musunuri B, Rajpurohit S, Shetty S, Bhat K, Pai CG. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe? Int Immunopharmacol 2023;116:109597. [PMID: 36702073 DOI: 10.1016/j.intimp.2022.109597] [Reference Citation Analysis]
2 Rajagopala SV, Strickland BA, Pakala SB, Kimura KS, Shilts MH, Rosas-Salazar C, Brown HM, Freeman MH, Wessinger BC, Gupta V, Phillips E, Mallal SA, Turner JH, Das SR. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load. J Virol 2023;:e0147822. [PMID: 36656015 DOI: 10.1128/jvi.01478-22] [Reference Citation Analysis]
3 Osuna-martínez U, Aviña-padilla K, Olimón-andalón V, Angulo-rojo C, Guadrón-llanos A, Rivas-ferreira JC, Urrea F, Calderon-zamora L. Discovering hub genes involved in the pathophysiological impact of COVID-19 on diabetes kidney disease by differential gene expression and interactome analysis.. [DOI: 10.1101/2022.10.11.511826] [Reference Citation Analysis]
4 Toro A, Lage-Vickers S, Bizzotto J, Vilicich F, Sabater A, Pascual G, Ledesma-Bazan S, Sanchis P, Ruiz MS, Arevalo AP, Porfido JL, Abbate M, Seniuk R, Labanca E, Anselmino N, Navone NM, Alonso DF, Vazquez E, Crispo M, Cotignola J, Gueron G. Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection. Viruses 2022;14:2180. [PMID: 36298734 DOI: 10.3390/v14102180] [Reference Citation Analysis]
5 Rajagopala SV, Strickland BA, Pakala SB, Kimura KS, Shilts MH, Rosas-salazar C, Brown HM, Freeman MH, Wessinger BC, Gupta V, Phillips E, Mallal SA, Turner JH, Das SR. Mucosal gene expression in response to SARS-CoV-2 is associated with early viral load.. [DOI: 10.1101/2022.08.23.504908] [Reference Citation Analysis]
6 Toro A, Lage-vickers S, Bizzotto J, Vilicich F, Sabater A, Pascual G, Ledesma-bazan S, Sanchis P, Ruiz MS, Arevalo AP, Porfido JL, Seniuk R, Labanca E, Anselmino N, Navone N, Alonso DF, Vazquez E, Crispo M, Cotignola J, Gueron G. Pin-pointing the key hubs in the IFN-γ pathway responding to SARS-CoV-2 infection.. [DOI: 10.1101/2022.07.22.22277931] [Reference Citation Analysis]
7 Stekel Z, Sheng Y, Zhang W. The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases. Biomolecules 2022;12:925. [DOI: 10.3390/biom12070925] [Reference Citation Analysis]
8 Yu C, Lauinger L, Kaiser P, Huang L. Protein Synthesis/Degradation: Protein Degradation – Intracellular – Ubiquitin, Ubiquitin-Like Proteins, and Proteasome-Mediated Degradation. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00227-3] [Reference Citation Analysis]